Intrathecal morphine remotely preconditions the heart via a neural pathway

Journal of Cardiovascular Pharmacology

Volumn 60, Issue 2, 2012, Pages 172-178

  Wong, Gordon Tin Chun ^a   Yao, Lu ^a,b   Xia, Zhengyuan ^a   Irwin, Michael G ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

cardiac protection; intrathecal morphine; ischemia reperfusion injury; opioids; preconditioning

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; BRADYKININ RECEPTOR; CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE RECEPTOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HEXAMETHONIUM; MORPHINE SULFATE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; REPERFUSION INJURY;

ANALGESICS, OPIOID; ANIMALS; APOPTOSIS; DISEASE MODELS, ANIMAL; HEART; INFUSIONS, SPINAL; MALE; MORPHINE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NEURAL PATHWAYS; NEUROTRANSMITTER AGENTS; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID; SPINAL CORD;

EID: 84865602259     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0b013e31825e2195     Document Type: Article

References (35)

1. ShiW, Vinten-Johansen J. Endogenous cardioprotection by ischaemic postconditioning and remote conditioning. Cardiovasc Res. 2012;94:206-216.
2. Hausenloy DJ, Yellon DM. Preconditioning and postconditioning: underlying mechanisms and clinical application. Atherosclerosis. 2009; 204:334-341.
3. Wong GTC, Ling Ling J, Irwin MG. Activation of central opioid receptors induces cardioprotection against ischemia-reperfusion injury. Anesthesia Analgesia. 2010;111:24-28.
4. Ling Ling J, Wong GT, Yao L, et al. Remote pharmacological postconditioning by intrathecal morphine: cardiac protection from spinal opioid receptor activation. Acta Anaesthesiol Scand. 2010;54:1097-1104.
5. Gross GJ, Hsu A, Nithipatikom K, et al. Eribis peptide 94 reduces infarct size in rat hearts via activation of centrally located [mu] opioid receptors. J Cardiovasc Pharmacol. 2011; Publish Ahead of Print.
6. Seyedi N, Win T, Lander HM, et al. Bradykinin B2-receptor activation augments norepinephrine exocytosis from cardiac sympathetic nerve endings: mediation by autocrine/paracrine mechanisms. Circ Res. 1997;81:774-784.
7. Kimura E, Hashimoto K, Furukawa S, et al. Changes in bradykinin level in coronary sinus blood after the experimental occlusion of a coronary artery. Am Heart J. 1973;85:635-647.
8. Matsuki T, Shoji T, Yoshida S, et al. Sympathetically induced myocardial ischaemia causes the heart to release plasma kinin. Cardiovasc Res. 1987;21:428-432.
9. Schoemaker RG, van Heijningen CL. Bradykinin mediates cardiac preconditioning at a distance. Am J Physiol Heart Circ Physiol. 2000;278: H1571-H1576.
10. Seyedi N, Maruyama R, Levi R. Bradykinin activates a cross-signaling pathway between sensory and adrenergic nerve endings in the heart: a novel mechanism of ischemic norepinephrine release? J Pharmacol ExpTher. 1999;290:656-663.
11. Wolfrum S, Nienstedt J, Heidbreder M, et al. Calcitonin gene related peptide mediates cardioprotection by remote preconditioning. Regul Pept. 2005;127:217-224.
12. Gao F, Gao E, Yue TL, et al. Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: the roles of PI3- kinase, Akt, and endothelial nitric oxide synthase phosphorylation. Circulation. 2002;105:1497-1502.
13. Hafezi-Moghadam A, Simoncini T, Yang Z, et al. Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase. Nat Med. 2002;8:473-479.
14. Bell RM, Yellon DM. Bradykinin limits infarction when administered as an adjunct to reperfusion in mouse heart: the role of PI3K, Akt and eNOS. J Mol Cell Cardiol. 2003;35:185-193.
15. Tsang A, Hausenloy DJ, Mocanu MM, et al. Postconditioning: a form of "modified reperfusion" protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway. Circul Res. 2004;95:230-232.
16. Uchiyama T, Engelman RM, Maulik N, et al. Role of Akt signaling in mitochondrial survival pathway triggered by hypoxic preconditioning. Circulation. 2004;109:3042-3049.
17. Hausenloy DJ, Tsang A, Yellon DM. The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning. Trends Cardiovasc Med. 2005;15:69-75.
18. Yaksh TL, Rudy TA. Chronic catheterization of the spinal subarachnoid space. Physiol Behav. 1976;17:1031-1036.
19. Li R, Wong GT, Wong TM, et al. Intrathecal morphine preconditioning induces cardioprotection via activation of delta, kappa, and mu opioid receptors in rats. Anesthesia Analgesia. 2009;108:23-29.
20. Jones WK, Fan G-C, Liao S, et al. Peripheral nociception associated with surgical incision elicits remote nonischemic cardioprotection via neurogenic activation of protein kinase C signaling. Circulation. 2009;120: S1-S9.
21. Schultz JEJ, Hsu AK, Gross GJ. Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibenclamide-sensitive mechanism in the rat heart. Circ Res. 1996;78:1100-1104.
22. Gross GJ. Role of opioids in acute and delayed preconditioning. J Mol Cell Cardiol. 2003;35:709-718.
23. Groban L, Vernon JC, Butterworth J. Intrathecal morphine reduces infarct size in a rat model of ischemia-reperfusion injury. Anesth Analg. 2004;98:903-909.
24. Mount PF, Kemp BE, Power DA. Regulation of endothelial and myocardial NO synthesis by multi-site eNOS phosphorylation. J Mol Cell Cardiol. 2007;42:271-279.
25. Yellon DM, Downey JM. Preconditioning the myocardium: from cellular physiology to clinical cardiology. Physiol Rev. 2003;83: 1113-1151.
26. Gho BC, Schoemaker RG, van den Doel MA, et al. Myocardial protection by brief ischemia in noncardiac tissue. Circulation. 1996;94: 2193-2200.
27. Kharbanda RK, Li J, Konstantinov IE, et al. Remote ischaemic preconditioning protects against cardiopulmonary bypass-induced tissue injury: a preclinical study. Heart. 2006;92:1506-1511.
28. Hausenloy DJ, Yellon DM. Remote ischaemic preconditioning: underlying mechanisms and clinical application. Cardiovasc Res. 2008;79: 377-386.
29. Konstantinov IE, Arab S, Kharbanda RK, et al. The remote ischemic preconditioning stimulus modifies inflammatory gene expression in humans. Physiol Genomics. 2004;19:143-150.
30. Konstantinov IE, Arab S, Li J, et al. The remote ischemic preconditioning stimulus modifies gene expression in mouse myocardium. J Thorac Cardiovasc Surg. 2005;130:1326-1332.
31. Brock SC, Tonussi CR. Intrathecally injected morphine inhibits inflammatory paw edema: the involvement of nitric oxide and cyclic-guanosine monophosphate. Anesth Analg. 2008;106:965-971.
32. Duncker DJ, van Zon NS, Pavek TJ, et al. Endogenous adenosine mediates coronary vasodilation during exercise after K(ATP)+ channel blockade. J Clin Invest. 1995;95:285-295.
33. Regan CP, Stump GL, Kane SA, et al. Calcitonin gene-related peptide receptor antagonism does not affect the severity of myocardial ischemia during atrial pacing in dogs with coronary artery stenosis. J Pharmacol Exp Ther. 2009;328:571-578.
34. Kumari R, Maulik M, Manchanda SC, et al. Protective effect of bradykinin antagonist Hoe-140 during in vivo myocardial ischemicreperfusion injury in the cat. Regulatory Peptides. 2003;115:211-218.
35. Devereaux PJ, Goldman L, Cook DJ, et al. Perioperative cardiac events in patients undergoing noncardiac surgery: a review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk. CMAJ. 2005;173:627-634.